ScholarWorks@Gachon: Yoo, Kwai Han

Detailed Information

Yoo, Kwai Han (유쾌한)

College of Medicine (Department of Medicine)

Research Area

Tel 032-458-2752
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Lymphoma:2||Doxorubicin:2||Asia:1||Autologous stem cell transplantation:1||Biliary tract cancer:1||Biomarker:1||Bronchusassociated lymphoid tissue:1||Busulfan:1||Carbon nanotube:1||Cardiotoxicity:1||Chronic lymphocytic leukemia:1||Cisplatin:1||Clinical outcomes:1||Clinical trial:1||Corticosteroids:1||Diffuse large Bcell lymphoma:1||EBV:1||Endosomal escape:1||Epidemiology:1||Epidermal growth factor receptor:1||Exogenous 8hydroxydeoxyguanosine:1||FDGPET/CT:1||Highrisk cytogenetics:1||Korea:1||Lenalidomide:1||Limited stage:1||Lugano classification:1||Lung:1||Mantle cell lymphoma:1||Marginal zone lymphoma:1||Melphalan:1||Mitochondrial damage:1||Multidrug resistant cell:1||Multiple myeloma:1||Mutation:1||Myeloma:1||NK/Tcell lymphoma:1||Nonsmall cell lung carcinoma:1||Older adults:1||Outcomes:1||PCR:1||Pegfilgrastim:1||Pemetrexed:1||Peripheral Tcell lymphoma:1||Prognosis:1||Prophylaxis:1||Pyroptosis:1||Quality of life:1||Refractory:1||Relapse:1||Response assessment:1||Responseadapted therapy:1||Small cell lung cancer:1||Staging:1||Stem cell transplantation:1||Survival:1||Treatment pattern:1||antiinflammation:1||antiviral therapy:1||bone marrow involvement:1||bone marrow study:1||diffuse large Bcell lymphoma:1||glioblastoma multiforme:1||hepatitis B virus:1||lymphoma diagnosis:1||lymphoma malignancies:1||mesenchymal stem cell:1||nanocarrier:1||nerve regeneration:1||prognosis:1||tenofovir disoproxil fumarate:1||tumor inhibition:1||.:1||words Diffuse large Bcell lymphoma:1||ATM:1||

RSS_1.0 RSS_2.0 ATOM_1.0

1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE